Aelius Biotech Launches Mucus Mondays - Aelius Biotech
M
in
in
in
in
PRESS RELEASE

Aelius Biotech Launches Mucus Mondays

A weekly series of facts on the physiological relevance of Mucus

Press Release 21st July 2025

Aelius Biotech Launches Mucus Mondays -- a weekly series of facts on the physiological relevance of Mucus

Aelius Biotech is delighted to announce the launch of Mucus Mondays, a weekly series of facts on LinkedIn.

Mucus is not just a barrier. It has many characteristics that means Mucus, and the principle component Mucin, has other pivotal roles in physiology -- key roles that are often overlooked when scientists are developing new functional foods, formulations and pharmaceuticals. The series of short facts will explain why Mucus should not be left out of in vitro models of the Gastro-intestinal tract.

First fact of Mucus Mondays:

𝗠𝘂𝗰𝘂𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗚𝘂𝘁 -- follow the link below;

https://www.linkedin.com/posts/aelius-biotech_mucusmondays-gutevolution-invitromodels-activity-7353048535245717506-7kVG?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAEaorUB3CI2jh9aJTw9GZ_HvQVCAI4D7lg

Aelius scientists are experts in the field of mucus and Gastro-intestinal modelling. Aelius Biotech offers the only combined digestion and absorption in vitro model in the world and can track from ingestion onwards. The model(s) support functional food, nutraceuticals and pharmaceutical development. Screening or bespoke solutions can be provided.

Contact details:

Dr Emma Mickley, Head of Business Development, Aelius Biotech, Newcastle; emma.mickley@aeliusbiotech.co.uk

Follow Mucus Mondays

Connect with us on LinkedIn for weekly insights into the critical role of mucus in GI modelling

Speak to an Expert

Press Release: Mucus Monday

We use cookies to give you the best experience.
Aelius Biotech - Footer